A single-center, prospective, comparative, patient-reported outcomes study was performed in patients who underwent fat grafting as an ancillary treatment after breast reconstruction at the Centre Hospitalier de l’Université de Montréal. This study was approved by the institutional ethics review board, and recruited patients scheduled for fat grafting after breast reconstruction between February 2016 and July 2018.
The same group of plastic surgeons performed all procedures. The indications for lipofilling were one or more of the following: hollowness (cavity), deformity (disruption of the form or shape of the breast), asymmetry, volume deficit, visible implant, rippling, or lack of projection.
Eligible patients included patients aged 18 years and older with an indication of fat grafting after breast-conserving surgery or total mastectomy with an implant or flap-based reconstruction. Patients who did not provide consent for the study, did not complete preoperative and postoperative BREAST-Q questionnaires, or were lost to follow-up were excluded.
The same group of plastic surgeons performed all procedures. The indications for lipofilling were one or more of the following: hollowness (cavity), deformity (disruption of the form or shape of the breast), asymmetry, volume deficit, visible implant, rippling, or lack of projection.
Eligible patients included patients aged 18 years and older with an indication of fat grafting after breast-conserving surgery or total mastectomy with an implant or flap-based reconstruction. Patients who did not provide consent for the study, did not complete preoperative and postoperative BREAST-Q questionnaires, or were lost to follow-up were excluded.
